GENE ONLINE|News &
Opinion
Blog

2022-01-19| IPO

Top 10 Biotech IPOs on NASDAQ in 2021

by GeneOnline
Share To
The 2025 J.P. Morgan Healthcare Conference highlights breakthroughs, strategic partnerships, and innovations in neurodegenerative diseases, cancer, and pain management.
Last year a record number of biotech companies went public on the NASDAQ.  With 128 biotech companies going public, 2021 destroyed the record set by 2020, which saw 99 companies debut. As GeneOnline advances its coverage of 2022, we decided to look back at the top 10 companies based on capital raised from their IPO. 

GO Prime with only $1.49 now

LATEST
Neuro, Pain, and Cancer Top the List at JPM 2025 Healthcare Conference
2025-01-17
ZYN Nicotine Pouches Receive FDA Marketing Authorization
2025-01-17
Virginia’s Insurance Marketplace Extends Open Enrollment Deadline: A Detailed Report
2025-01-16
2025 Starts with a Jolt: Layoffs Hit the Life Sciences Industry Ahead of JPM
2025-01-16
Eli Lilly Steals the Spotlight at JPM 2025 with $2.5 Billion Power Move Acquisition
2025-01-16
Pre-JPM 2025: The Quiet Deals You May Have Missed Before the Big Show
2025-01-16
JPM 2025’s Billion Dollar Deal – GSK Bids Big in GI Cancer
2025-01-15
EVENT
2025-02-05
Precision Medicine World Conference 2025
Santa Clara, California
2025-02-19
Healthcare Conference Taipei 2025
Taipei, Taiwan
2025-03-17
BIO-Europe Spring 2025
Milan, Italy
2025-04-21
World Vaccine Congress 2025
Washington, U.S.A
2025-04-25
AACR Annual Meeting 2025
Chicago, U.S.A
Scroll to Top